Rostrum Training
Rostrum is more than just a training company. We are dedicated to the European pharmaceutical industry, and our training courses are supported by a full range of services that help people and organisations make the most of their training.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Launch excellence
Press Releases | April 12, 2022 | Lucid Group Communications Limited
In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...
Case Study: Reducing Travel-Related Emissions and Costs Through Virtual Events
White Papers and Resources | April 11, 2022 | Impetus Digital
In early 2021, due to COVID-19-related safety concerns and travel and social distancing restrictions, our client needed help to “virtualize” their nationwide, multi-day, multi-business unit internal event with 375 attendees....
Meet The Lucid Group Talent Team
Videos and Podcasts | April 11, 2022 | Lucid Group Communications Limited
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...
Celebrating the new UK rare diseases framework
White Papers and Resources | April 8, 2022 | Dice Medical Communications
Dice's take on the importance of the rare diseases framework
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Videos and Podcasts | April 8, 2022 | Impetus Digital
A version of this article was previously published on Pharmaphorum.There is not a single industry that has been left untouched by COVID-19. While the effects of the pandemic have been devastating...
Data-Driven Approaches for Neurorecovery
Videos and Podcasts | April 7, 2022 | Impetus Digital
Yotam Drechsler (Co-founder/CEO) and Yaron Segal (Co-founder/CINO) from BrainQ Technologies dives into the roles of Brain-Computer Interface technologies and electrophysiology measurements in aiding neurorecovery, the role of AI and machine...
UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS
Press Releases | April 6, 2022 | Wilmington Healthcare
Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...
What do we really value as a society?
White Papers and Resources | April 5, 2022 | Dice Medical Communications
'A third of older people in our society die with dementia. A third.' Will the government invest more to help find a cure? (Article written 14th June 2021).
Online Advisory Boards: Top 10 Frequently Asked Questions
White Papers and Resources | April 4, 2022 | Impetus Digital
It’s hard to imagine a time when some people in the life science industry had never attended a web meeting. Yet, that’s the reality we were living in just two...
Webcast: Demand Assessment
White Papers and Resources | April 4, 2022 | Inizio
Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.